ReviewMaterials today. Bio2026
Multiscale biomimetic design for peripheral nerve repair: Beyond passive bridging.
Review in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral nerve injury persists as a formidable clinical challenge, particularly in long-gap and complex lesions where surgical intervention frequently yields suboptimal functional restoration. Current nerve guidance conduits (NGCs) afford limited advantage owing to their passive bridging nature, incapable of recapitulating the native nerve's hierarchical architecture, bioactive microenvironment, or temporally coordinated repair programs. Informed by bibliometric and meta-analytic evidence, this review redefines biomimetic peripheral nerve repair as an orchestrated transition from passive bridging to biologically instructed, adaptive neural interfaces. Departing from a mere enumeration of structural, functional, spatiotemporal, and cross-species biomimicry, each axis is endowed with a specific functional mandate. Structural biomimicry imposes directional and hierarchical guidance, functional biomimicry re-establishes the regenerative niche, spatiotemporal biomimicry synchronizes with stage-dependent repair requirements, and cross-species biomimicry expands the reservoir of transferable design principles. The ways in which these cues converge, compete, or synergize within composite conduits are systematically examined, together with the imperative of prioritizing their configurations for manufacturability, sterilization, regulatory feasibility, and long-gap validation. This synthesis crystallizes a design logic for next-generation NGCs, guiding their evolution from static scaffolds toward adaptive, manufacturable, and clinically translatable regenerative interfaces.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.